NASDAQ · Medical - Healthcare Information Services

NUTX (NUTX) Stock

$148.71 +5.85% NASDAQ: NUTX Healthcare

Valuation

MetricValue
Price$148.71
Market Cap$1.02B
P/E Ratio10.79
P/B Ratio2.96
P/S Ratio1.00
EPS (TTM)$13.67
52-Week High$204.20
52-Week Low$77.21
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE53.65%
ROA28.59%
ROCE65.09%
Gross Margin47.47%
Operating Margin31.39%
Net Margin10.95%
Debt/Equity1.01
Current Ratio3.41

Annual Financials (USD)

Metric20212022202320242025
Revenue$332.0M$219.0M$248.0M$480.0M$875.0M
Operating Profit$170.0M$-407.0M$-32.0M$131.0M$276.0M
Net Profit$133.0M$-425.0M$-46.0M$52.0M$71.0M
EPS$33.55$-100.36$-10.39$9.71$10.48
Op Margin51.4%-185.4%-12.8%27.2%31.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$395.0M$432.0M$398.0M$655.0M$919.0M
Total Liabilities$203.0M$311.0M$319.0M$453.0M$495.0M
Cash$36.0M$34.0M$22.0M$44.0M$186.0M
Borrowings$179.0M$267.0M$276.0M$340.0M$351.0M

Latest News

Why Nutex Health’s (NUTX) Microhospital Economics Put Reimbursement at the Center of Its Upside Case Insider Monkey · Jul 7, 2026 B. Riley Initiates Coverage on Nutex Health With Buy Rating, $290 Price Target MT Newswires · Jun 26, 2026 3 Undervalued Small Caps With Insider Action Across Regions Simply Wall St. · Jun 2, 2026 Nutex Health NUTX Q1 2025 Earnings Transcript Motley Fool · May 4, 2026 Nutex Health NUTX Q2 2025 Earnings Transcript Motley Fool · May 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$173.0M$51.0M$1.0M$23.0M$248.0M
Investing Cash Flow$-74.0M$-19.0M$-21.0M$-5.0M$-8.0M
Financing Cash Flow$22.0M$4.0M$0$6.0M$-4.0M
Net Cash Flow$11.0M$-2.0M$-12.0M$22.0M$145.0M
Free Cash Flow$137.0M$36.0M$-8.0M$21.0M$246.0M

Valuation & Return Ratios

MetricValue
PEG Ratio30.25
EV / EBITDA2.97
FCF Yield30.43%
Quick Ratio3.12
Interest Coverage12.55
Return 1Y65.30%
Return 3Y160.49%
Return 5Y—

Ownership

Insiders Held29.06%
Institutions Held42.51%
Institutions Float Held59.93%
Institutional HolderSharesReport Date
Blackrock Inc.379,3552026-03-31
Pertento Partners LLP373,9702026-03-31
Vanguard Capital Management LLC219,1312026-03-31
American Century Companies Inc203,4502026-03-31
Topline Capital Management, LLC177,8002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMN $31.17 -4.97% -11.68 $1.21B 0.00%
BFLY $8.28 -1.72% -60.65 $2.20B 0.00%
CDNA $43.71 +14.72% 18.87 $2.26B 0.00%
DAWNDay One Biopharmaceuticals, Inc. $21.53 +0.00% -20.70 $2.22B 0.00%
DNA $8.07 -0.19% -1.30 $527.50M 0.00%

About NUTX

NUTX is led by CEO Thomas T. Vo, employs 800 people, headquartered in US, publicly traded since 2022.

NUTX stock trades at $148.71 with a market capitalization of $1.02B. The stock is valued at a price-to-earnings (P/E) ratio of 10.79, price-to-book of 2.96, price-to-sales of 1.00. Over the past 52 weeks the stock has ranged between $77.21 and $204.20, and currently trades 27.2% below its 52-week high.

On profitability, NUTX generates a return on equity (ROE) of 53.65% — well above the market average, a sign of a high-quality business, return on capital employed of 65.09%, an operating margin of 31.39%, a net profit margin of 10.95%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides